Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-13 Sale |
2021-10-13 8:24 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $55.97 | $559,675 | 251,807 (Direct) |
View |
| 2021-07-13 Sale |
2021-07-14 4:28 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $80.88 | $808,777 | 261,807 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-13 8:21 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $68.07 | $680,723 | 271,807 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-21 4:31 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $78.7 | $787,016 | 283,258 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-04 Option Award |
2024-01-08 9:13 pm |
N/A 2034-01-03 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
81,156 | $0 | 293,363 (Direct) |
View |
| 2024-01-05 Tax Withholding |
2024-01-08 9:13 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
2,197 | $37.96 | 293,363 (Direct) |
View |
| 2024-01-08 Tax Withholding |
2024-01-08 9:13 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
3,535 | $41.53 | 293,363 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:06 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
5,720 | $0 | 217,939 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,068 | $26.41 | 212,219 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:00 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
2,452 | $27.52 | 348,287 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:00 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
157,663 | $0 | 348,287 (Direct) |
View |
| 2022-07-18 Tax Withholding |
2022-07-20 6:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,551 | $28.47 | 193,076 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:30 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
6,092 | $0 | 194,627 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,181 | $56.06 | 188,535 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,772 | $56.06 | 187,944 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:25 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
91,412 | $0 | 258,923 (Direct) |
View |
| 2021-10-13 Exercise |
2021-10-13 8:24 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 251,807 (Direct) |
View |
| 2021-10-13 Exercise |
2021-10-13 8:24 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 251,807 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-14 4:28 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 261,807 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-14 4:28 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 261,807 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 8:21 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 271,807 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 8:21 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 271,807 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 4:31 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,128 | $1.65 | 283,258 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 4:31 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
8,872 | $2.3 | 283,258 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 4:31 pm |
N/A 2029-03-19 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 283,258 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:30 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
99,000 | $0 | 255,511 (Direct) |
View |